Schedule 13G ownership disclosure

Agios Pharmaceuticals Inc

Common Stock, par value $0.001 per share (the "Shares") · CUSIP: 00847X104

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Farallon Capital Partners, L.P.

    Shares: 422,479 · Class: 0.7%

  • Farallon Capital Institutional Partners, L.P.

    Shares: 480,410 · Class: 0.8%

  • Farallon Capital Institutional Partners II, L.P.

    Shares: 141,724 · Class: 0.2%

  • Farallon Capital Institutional Partners III, L.P.

    Shares: 52,905 · Class: 0.1%

  • Four Crossings Institutional Partners V, L.P.

    Shares: 97,097 · Class: 0.2%

  • Farallon Capital Offshore Investors II, L.P.

    Shares: 866,239 · Class: 1.5%

  • Farallon Capital (AM) Investors, L.P.

    Shares: 62,523 · Class: 0.1%

  • Farallon Capital F5 Master I, L.P.

    Shares: 222,073 · Class: 0.4%

  • Farallon Healthcare Partners Master, L.P.

    Shares: 3,329,016 · Class: 5.8%

  • Farallon Partners, L.L.C.

    Shares: 5,452,393 · Class: 9.6%

  • Farallon Institutional (GP) V, L.L.C.

    Shares: 97,097 · Class: 0.2%

  • Farallon F5 (GP), L.L.C.

    Shares: 222,073 · Class: 0.4%

  • Farallon Healthcare Partners (GP), L.L.C.

    Shares: 3,329,016 · Class: 5.8%

  • Dapice Joshua J.

    Shares: 5,674,466 · Class: 9.9%

  • Dreyfuss, Philip D.

    Shares: 5,674,466 · Class: 9.9%

  • Dunn Hannah E.

    Shares: 5,674,466 · Class: 9.9%

  • Fried, Richard B

    Shares: 5,674,466 · Class: 9.9%

  • Gehani, Varun N.

    Shares: 5,674,466 · Class: 9.9%

  • Giauque, Nicolas

    Shares: 5,674,466 · Class: 9.9%

  • Kim, David T.

    Shares: 5,674,466 · Class: 9.9%

  • Linn, Michael G.

    Shares: 5,674,466 · Class: 9.9%

  • Luo Patrick (Cheng)

    Shares: 5,674,466 · Class: 9.9%

  • Patel, Rajiv A.

    Shares: 5,674,466 · Class: 9.9%

  • Roberts, Jr., Thomas G.

    Shares: 5,674,466 · Class: 9.9%

  • Saito Edric C.

    Shares: 5,674,466 · Class: 9.9%

  • Seybold, William

    Shares: 5,674,466 · Class: 9.9%

  • Short Daniel S.

    Shares: 5,674,466 · Class: 9.9%

  • Spokes, Andrew J. M.

    Shares: 5,674,466 · Class: 9.9%

  • Warren, John R.

    Shares: 5,674,466 · Class: 9.9%

  • Wehrly, Mark C.

    Shares: 5,674,466 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000908834-25-000038
Form type
SCHEDULE 13G/A
Filer
AGIOS PHARMACEUTICALS, INC.
CIK
CIK 1439222
Filed
Feb 04, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub